PROTEOMICS INTERNATIONAL LABORATORIES LIMITED

Autres langues Proteomics International Laboratories Limited

Actions

PIQ

AU000000PIQ0

Temps Différé Australian S.E. Autres places de cotation 03:13:16 29/04/2024			Varia. 5j.	Varia. 1 janv.
1,1 ^AUD	+0,46 %		-0,90 %	+22,91 %

25/03	Proteomics International signe un accord avec l'Université d'Oxford pour une étude sur l'endométriose	MT
19/03	Proteomics retarde le lancement de PromarkerD aux États-Unis	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Proteomics International Laboratories Ltd March 2024 Quarterly Activities Report	16/04
Proteomics International Laboratories Ltd Investor Presentation	28/03
Proteomics International Signs Agreement with University of Oxford for Endometriosis Study	25/03
Proteomics International Laboratories Ltd Signs With Oxford University to Validate Test for Endometriosis	24/03
Proteomics Says PromarkerD's US Launch Delayed	19/03
Proteomics International Laboratories Ltd PromarkerD US Commercialisation and Promarker Pipeline Update	17/03
Proteomics International Laboratories Secures ISO 13485 Certification Renewal	06/03
Proteomics International Laboratories Ltd Retains its ISO13485 Certification	05/03
Proteomics International Laboratories Ltd European Patent Granted for OxiDx Technology	27/02
Proteomics International Laboratories Narrows Fiscal H1 Loss	23/02
Proteomics International Laboratories Limited Reports Earnings Results for the Half Year Ended December 31, 2023	23/02
Proteomics International Laboratories Ltd Investor presentation - Euroz Hartleys Healthcare Forum	05/02
Proteomics International's Blood Test for Uterine Disease Undergoes Biomarker Validation	01/02
Proteomics International's Blood Test for Throat Cancer Undergoes Biomarker Validation	01/02
Proteomics International Laboratories Ltd Study Validates Biomarkers for Oesophageal Cancer Blood Test	31/01
Proteomics International Laboratories Ltd Study Validates Biomarkers for Endometriosis Blood Test	31/01
Proteomics International Laboratories Raises AU$6.5 Million for Test Commercialization, Further Development; Shares Down 10%	23/01
Proteomics International Laboratories Ltd To Raise $6.5m Through Institutional Placement	22/01
Proteomics International Laboratories Ltd December 2023 Quarterly Activities Report	22/01
Proteomics Signs Deal to Sell PromarkerD in Chile; Shares Jump 5%	20/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Proteomics International Laboratories Limited

Actions

PIQ

AU000000PIQ0

Autres langues

Filtres